David S. Thiriot, Ph.D.
Affiliations: | 2001 | University of Wisconsin, Madison, Madison, WI |
Area:
Molecular mechanisms which underlie neurotransmitter release and receptor activationGoogle:
"David Thiriot"Mean distance: 21373.2
Parents
Sign in to add mentor| Arnold E Ruoho | grad student | 2001 | UW Madison | |
| (Engineering the human vesicle monoamine transporter to study structure, function, and ligand binding sites.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Thiriot DS, Sievert MK, Ruoho AE. (2002) Identification of human vesicle monoamine transporter (VMAT2) lumenal cysteines that form an intramolecular disulfide bond. Biochemistry. 41: 6346-53 |
| Thiriot DS, Ruoho AE. (2001) Mutagenesis and derivatization of human vesicle monoamine transporter 2 (VMAT2) cysteines identifies transporter domains involved in tetrabenazine binding and substrate transport. The Journal of Biological Chemistry. 276: 27304-15 |
| Wu Z, Thiriot DS, Ruoho AE. (2001) Tyr199 in transmembrane domain 5 of the beta2-adrenergic receptor interacts directly with the pharmacophore of a unique fluorenone-based antagonist. The Biochemical Journal. 354: 485-91 |
| Rong Y, Arbabian M, Thiriot DS, et al. (1999) Probing the salmeterol binding site on the beta 2-adrenergic receptor using a novel photoaffinity ligand, [(125)I]iodoazidosalmeterol. Biochemistry. 38: 11278-86 |
| Sievert MK, Thiriot DS, Edwards RH, et al. (1998) High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells. The Biochemical Journal. 330: 959-66 |